| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding Corp. (TNXP) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 7 sells. TNXP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 39.0K | $475.9K | - | |
| CFO | 39.0K | $475.9K | - | |
| Other | 39.0K | $475.9K | - | |
| Other | 39.0K | $475.9K | - | |
| CEO | 20.0K | $244.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2017 | Lederman Seth | Chief Executive Officer | Buy | 5,300 | $3.61 | $19,133.00 | +30.5% | |
| Dec 21, 2017 | Mario Ernest | Director | Sell | 36,967 | $3.51 | $129,814.31 | -13.3% | |
| Aug 17, 2017 | Lederman Seth | Chief Executive Officer | Buy | 20,000 | $3.00 | $60,017.50 | +30.8% | |
| Jun 30, 2017 | Mario Ernest | Director | Sell | 6,105 | $4.28 | $26,117.19 | -50.9% | |
| Jun 30, 2017 | Lederman Seth | Chief Executive Officer | Buy | 5,000 | $4.33 | $21,640.00 | +20.0% | |
| Jun 26, 2017 | Lederman Seth | Chief Executive Officer | Buy | 5,000 | $4.40 | $21,999.50 | +25.0% | |
| Jun 20, 2017 | Lederman Seth | Chief Executive Officer | Buy | 20,000 | $4.22 | $84,400.00 | New | |
| Nov 23, 2016 | Mario Ernest | Director | Buy | 120,000 | $0.41 | $48,600.00 | New | |
| Nov 21, 2016 | Lederman Seth | Chief Executive Officer | Buy | 98,000 | $0.43 | $41,924.40 | +280.0% | |
| Oct 31, 2016 | Lederman Seth | Chief Executive Officer | Buy | 10,000 | $0.00 | - | +12.4% |